Analysis and Evaluation of International Information about Corona Virus Disease 2019 (COVID-19)
- VernacularTitle: 新型冠状病毒肺炎诊疗国际信息资源的分析与评价
- Author:
Zai-Wei SONG
1
Author Information
- Publication Type:Journal Article
- Keywords: Analysis; Clinical management; COVID-19; Evaluation; International information; SARS-CoV-2
- From: Chinese Pharmaceutical Journal 2020;55(10):784-788
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To analyze and evaluate the international information about coronavirus disease 2019 (COVID-19), and provide reference for prevention and control of the epidemic. METHODS: International information about COVID-19 from World Health Organization (WHO), Centers for Disease Control and Prevention, US (CDC), European Centre for Disease Prevention and Control (ECDC), Department of Health, Australian Government (AGDH), Department of Health & Social Care, UK (UKDH), the International Pharmaceutical Federation (FIP) were retrieved and summarized. The timeliness, comprehensiveness and applicability of the international information were evaluated descriptively. Technical guidance about clinical management and pharmaceutical work of pharmacists were analyzed. RESULTS: Information from WHO, CDC, ECDC, AGDH, UKDH and FIP were generally detailed, with timeliness, comprehensiveness and a certain applicability. WHO focused on global perspective and provided clinical management guidance, and FIP focused on pharmacist and pharmaceutical work and provided information about clinical medication. CONCLUSION: When referring to international information about COVID-19, the actual situation should be taken into consideration, and subsequently the information should be applied cautiously to help prevent and control the epidemic of COVID-19.
